SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000909661-08-000036
Filing Date
2008-02-01
Accepted
2008-02-01 17:27:32
Documents
1
Group Members
ANDREW J.M. SPOKESASHISH H. PANTDAVID I. COHENDEREK C. SCHRIERDOUGLAS M. MACMAHONFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL OFFSHORE INVEST

Document Format Files

Seq Description Document Type Size
1 13D IN PHARMION CORP pharmion13d.htm SC 13D 1371548
  Complete submission text file 0000909661-08-000036.txt   1374421
Mailing Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111 (415)421-2132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279
Type: SC 13D

Mailing Address
Business Address 2525 28TH STREET BOULDER CO 80301 720 564 9100
PHARMION CORP (Subject) CIK: 0001203866 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79338 | Film No.: 08569673
SIC: 2834 Pharmaceutical Preparations